PepGen Ltd (PEPG)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $410.98M
Last updated: Nov 17, 2026 at 11:05 AM ET
PepGen Ltd (PEPG) Stock Forecast
Analysts expect PepGen (PEPG) to earn -$1.08 per share in the fiscal year ending Dec 31, 2026. Of 8 analysts, 7 rate the stock Buy or Strong Buy, 0 Hold and 1 Sell or Strong Sell, for a consensus of Buy. Over the last 30 days, 0 estimates for the fiscal year ending Dec 31, 2026 were revised up and 1 down.
Analyst Ratings
Scoring Strong Buy as 1 and Strong Sell as 5, the 8 ratings average 2.38, inside the Buy band from 1.5 up to 2.5. Buy and Strong Buy make up 88% of the ratings.
| Rating | Analysts | Share |
|---|---|---|
| Strong Buy | 0 | 0.0% |
| Buy | 7 | 87.5% |
| Hold | 0 | 0.0% |
| Sell | 0 | 0.0% |
| Strong Sell | 1 | 12.5% |
- Consensus
- Buy
- Total analysts
- 8
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus shows a larger loss.
- Fiscal year ending Dec 31, 2026
- -$1.08
- EPS consensus
- Fiscal year ending Dec 31, 2027
- -$1.16
- EPS consensus
- Next report
- Mar 2, 2027
- Estimated
EPS range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts |
|---|---|---|---|
| Dec 31, 2026 | -$1.08 | -$1.20 to -$1.01 | 6 |
| Dec 31, 2027 | -$1.16 | -$1.78 to -$0.73 | 6 |
Quarterly Estimates
The EPS consensus rises from -$0.31 for the quarter ending Dec 31, 2026 to -$0.28 for the quarter ending Mar 31, 2027.
EPS range
| Quarter ending | EPS consensus | EPS range | EPS analysts |
|---|---|---|---|
| Dec 31, 2026 | -$0.31 | -$0.55 to -$0.24 | 10 |
| Mar 31, 2027 | -$0.28 | -$0.32 to -$0.23 | 2 |
Estimate Revisions
Across the 3 periods below, the last 30 days brought 0 upward and 2 downward EPS revisions.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Dec 31, 2026 | 0 | 1 |
| Fiscal year ending Dec 31, 2027 | 0 | 1 |
| Quarter ending Mar 31, 2027 | 0 | 0 |
EPS Trend
Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has worsened from -$1.07.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Dec 31, 2026 | -$1.08 | -$1.10 | -$1.10 | -$1.07 | -$1.07 | N/A |
| Fiscal year ending Dec 31, 2027 | -$1.16 | -$1.06 | -$1.06 | -$1.04 | -$1.04 | N/A |
| Quarter ending Mar 31, 2027 | -$0.28 | -$0.25 | -$0.25 | -$0.25 | -$0.25 | N/A |
Frequently Asked Questions About PEPG
What is the PEPG stock forecast?
Consensus analyst estimates put PepGen's EPS at -$1.08 for the fiscal year ending Dec 31, 2026. The consensus rating from 8 analysts is Buy.
How do analysts rate PEPG stock?
Of 8 analysts covering PepGen, 0 rate it Strong Buy, 7 Buy, 0 Hold, 0 Sell and 1 Strong Sell, for a consensus of Buy.
What EPS do analysts expect from PEPG next year?
For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is -$1.08, with estimates from -$1.20 to -$1.01 from 6 analysts. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is -$1.16, with estimates from -$1.78 to -$0.73 from 6 analysts.
How many analysts cover PEPG?
8 analysts rate PepGen stock, and 6 analysts estimate its EPS for the fiscal year ending Dec 31, 2026.
PEPG pages: Overview, Earnings, Forecast, Financials, Competitors